A detailed history of Oxford Financial Group LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Oxford Financial Group LTD holds 3,900 shares of NVO stock, worth $331,500. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,900
Previous 3,980 2.01%
Holding current value
$331,500
Previous $568,000 18.31%
% of portfolio
0.03%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $9,525 - $11,633
-80 Reduced 2.01%
3,900 $464,000
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $111,666 - $133,688
910 Added 29.64%
3,980 $568,000
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $1,123 - $1,495
-11 Reduced 0.36%
3,070 $394,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $4,476 - $5,377
51 Added 1.68%
3,081 $318,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $23,371 - $51,281
257 Added 9.27%
3,030 $275,000
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $432,532 - $478,758
2,773 New
2,773 $448,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Oxford Financial Group LTD Portfolio

Follow Oxford Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.